1. Home
  2. OPRX vs PYXS Comparison

OPRX vs PYXS Comparison

Compare OPRX & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OptimizeRx Corporation

OPRX

OptimizeRx Corporation

HOLD

Current Price

$12.35

Market Cap

245.7M

ML Signal

HOLD

Logo Pyxis Oncology Inc.

PYXS

Pyxis Oncology Inc.

HOLD

Current Price

$1.08

Market Cap

243.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPRX
PYXS
Founded
2006
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.7M
243.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
OPRX
PYXS
Price
$12.35
$1.08
Analyst Decision
Buy
Strong Buy
Analyst Count
6
4
Target Price
$14.83
$6.75
AVG Volume (30 Days)
242.0K
1.7M
Earning Date
11-06-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$109,506,000.00
$2,820,000.00
Revenue This Year
$19.77
N/A
Revenue Next Year
$11.33
N/A
P/E Ratio
$6,842.22
N/A
Revenue Growth
24.18
N/A
52 Week Low
$3.99
$0.83
52 Week High
$22.25
$5.55

Technical Indicators

Market Signals
Indicator
OPRX
PYXS
Relative Strength Index (RSI) 31.29 20.62
Support Level $12.66 $1.03
Resistance Level $13.78 $4.58
Average True Range (ATR) 0.60 0.29
MACD 0.01 -0.32
Stochastic Oscillator 2.97 1.13

Price Performance

Historical Comparison
OPRX
PYXS

About OPRX OptimizeRx Corporation

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Share on Social Networks: